Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by National Cancer Centre, Singapore.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
National Cancer Centre, Singapore
ClinicalTrials.gov Identifier:
NCT01540110
First received: January 31, 2012
Last updated: February 22, 2012
Last verified: August 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)